Type 2 diabetes and cardio-vascular disease often occur together and scientists have now discovered that the two diseases may be related at the level of genes, proteins and fundamental physiology.
The study could lead to the common treatment for both diseases.
The two diseases share eight molecular pathways and several "key driver" genes appear to orchestrate the gene networks in which these pathways connect and interact, the findings showed.
"These (key driver) genes represent central network genes which, when perturbed, can potentially affect a large number of genes involved in the CVD (cardio-vascular) and T2D (Type 2 diabetes) pathways and thus exert stronger impact on diseases," said co-senior author Xia Yang of the University of California, Los Angeles in the US.
"We were able to derive novel mechanistic insights and identify potential therapeutic targets," the researchers added.
The researchers gathered genetic and health information from more than 15,000 women.
The scientists started by looking for individual genetic differences in women of three different ethnicities, who had either or both of the conditions compared to similar but healthy women - a technique called Genome Wide Association Study (GWAS).
But the team members did not stop there. They also analysed the women's genetic differences in the context of the complex pathways, where genes and their protein products interact to affect physiology and health.
In comparing women with cardio-vascular diseases and and Type 2 diabetes to healthy women, team found key differences in eight pathways regulating cell adhesion (how cells stick within tissues), calcium signalling (how cells communicate), axon guidance (how neurons find their paths to connect with target sites), extra-cellular matrix (structural support within tissue), and various forms of cardiomyopathy (heart muscle problems).
The study appeared in the journal Circulation: Cardiovascular Genetics.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
